08 June 2021>: Original Paper
Application of Metagenomic Next-Generation Sequencing to Diagnose Pneumonia in Kidney Transplantation Recipients
Jia Xu 12345ABCDEF , Yedong Yu 12345ABCD , Junhao Lv 12345ABCD , Sisi Yang 6ABCD , Jianyong Wu 12345AD , Jianghua Chen 12345AD , Wenhan Peng 12345AEFG*DOI: 10.12659/AOT.931059
Ann Transplant 2021; 26:e931059
Table 1 Baseline characteristics.
Recipient | Age (yr) | Gender | BMI (kg/m2) | RD | Dialysis form | Dialysis time | Transplant time | Transplant form | Hypertension | Diabetes | LVEF (%) | Immunosuppressant |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 64 | Male | 22.5 | Unknown | PD | 4 (yr) | 1 (yr) | DCD | + | − | 60 | Tacrolimus +MMF +GC |
2 | 36 | Male | 20.4 | Unknown | HD | 0.5 (yr) | 5 (yr) | Living-related | + | − | n/a | Tacrolimus +MMF +GC |
3 | 34 | Male | 17.9 | Unknown | HD | 4 (yr) | 5 (month) | DCD | + | − | 61 | Tacrolimus +MMF +GC |
4 | 62 | Male | 21.6 | Unknown | PD | 4 (yr) | 2 (yr) | DCD | + | + | 69 | CsA +MPA +GC |
5 | 40 | Male | 19.8 | Polycystic kidney | HD | 5 (yr) | 1 (yr) | DCD | + | − | n/a | Tacrolimus +MMF +GC |
6 | 54 | Male | 25.3 | Diabetic nephropathy | HD | 8 (yr) | 5 (month) | DCD | + | + | 59 | Tacrolimus +MMF +GC |
7 | 45 | Female | 17.5 | Unknown | PD | 0.5 (yr) | 9 (yr) | DCD | + | − | 85 | Tacrolimus +MMF +GC |
8 | 30 | Male | 20.5 | Unknown | HD | 10 (month) | 1 (yr) | Living-related | + | − | 62 | Tacrolimus +MMF +GC |
9 | 43 | Male | 21.0 | Unknown | HD | 1 (month) | 9 (yr) | Living-related | + | − | 64 | Tacrolimus +MMF +GC |
10 | 35 | Female | 17.3 | HSP | None | 0 | 1 (yr) | Living-related | + | − | n/a | Tacrolimus +MMF +GC |
11 | 61 | Male | 19.9 | Unknown | HD | 9 (yr) | 5 (month) | DCD | + | − | 70 | Tacrolimus +MMF +GC |
12 | 28 | Male | 23.2 | Unknown | None | 0 | 1 (yr) | Living-related | + | − | n/a | Tacrolimus +MMF +GC |
BMI – body mass index; RD – renal disease; HSP – Henoch-Schönlein purpura nephritis; PD – peritoneal dialysis; HD – hemodialysis; DCD – cardiac death donors; LVEF – left ventricular ejection fractions; CsA – ciclosporin; MMF – mycophenolate mofetil; MPA – mycophenolic acid; GC – glucocorticoid; n/a – not available; ‘+’ – positive; ‘−’ – negative. |